Showing 21-30 of 48 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Development of Uni-molecular Glucose-responsive Insulin | Stanford University | Danny Hung-Chieh Chou | Improving Lives | 01-April-2022 to 31-March-2026 | $749,998.34 |
| Restoration of Treg function to prevent progression to hyperglycemia | Stanford University | C. Garrison Fathman | Cures | 01-June-2022 to 31-May-2025 | $600,000.00 |
| Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D | Stanford University | Ananta Addala | Improving Lives | 01-February-2025 to 31-January-2029 | $943,983.20 |
| Network-based Systems Biology for T1D Drug Repositioning | The Regents of the University of California, Los Angeles | Xia Yang | Improving Lives | 01-May-2021 to 30-November-2025 | $780,961.09 |
| Multiplex in vivo imaging of the dynamics of immune-mediated rejection of allogenic islet grafts | The Regents of the University of California, Los Angeles | Oluwatayo Ikotun | Cures | 01-February-2024 to 31-January-2027 | $749,996.25 |
| Antigen-specific immunotherapies based on ignored ß-cell antigen determinants. | The Regents of the University of California, Los Angeles | Daniel Kaufman | Cures | 01-October-2024 to 30-September-2026 | $573,101.00 |
| Prediction of Cancer Immunotherapy Precipitated Autoimmune Diabetes | The Regents of the University of California, San Francisco | Zoe Quandt | Cures | 01-March-2025 to 28-February-2030 | $1,000,000.00 |
| Investigating MAFA governed mechanisms underlying β-cell functional maturation and dysfunction using hPSC-derived β-cells | The Regents of the University of California, San Francisco | Veronica Cochrane | Cures | 01-July-2024 to 28-February-2027 | $231,222.03 |
| Allogeneic hypoimmunogenic Pancreatic Islets for Treatment of Diabetes in the Intra-Muscular Site | The Regents of the University of California, San Francisco | Tobias Deuse | Cures | 01-August-2024 to 31-July-2026 | $799,998.40 |
| Identifying regulators of primary human beta cell survival and proliferation | The Regents of the University of California, San Francisco | Rebecca Lee | Cures | 01-March-2024 to 28-February-2027 | $235,025.00 |